Ensysce Biosciences, Inc. (ENSC) — 分析师展望 / 分析师共识目标价为. 基于 2 位分析师评级, 共识为 看涨 — 2 买入.
分析师预估 每股收益(EPS)为 $-8.34 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-4.57 vs 预期 $-8.34 (超预期 +45.2%). 2025: 实际 $-3.98 vs 预期 $-4.73 (超预期 +15.9%). 分析师准确度: 49%.
ENSC 分析师评级
Buy
基于过去3个月内 2 位分析师对 Ensysce Biosciences, Inc. 的评级
EPS 预测 — ENSC
49%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$4.57
vs Est –$8.34
▲ 82.4% off
2025
Actual –$3.98
vs Est –$4.73
▲ 18.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — ENSC
80%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.005B
vs Est $0.004B
▲ 20.3% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
